Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for Alignment Healthcare (ALHC) over the last 4 years, with Q3 2025 value amounting to $208.9 million.

  • Alignment Healthcare's Shares Outstanding (Diluted Average) rose 917.99% to $208.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.9 million, marking a year-over-year increase of 917.99%. This contributed to the annual value of $190.8 million for FY2024, which is 245.89% up from last year.
  • Alignment Healthcare's Shares Outstanding (Diluted Average) amounted to $208.9 million in Q3 2025, which was up 917.99% from $209.5 million recorded in Q2 2025.
  • Over the past 5 years, Alignment Healthcare's Shares Outstanding (Diluted Average) peaked at $209.5 million during Q2 2025, and registered a low of $181.2 million during Q4 2022.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $191.5 million, with a median of $189.9 million in 2024.
  • As far as peak fluctuations go, Alignment Healthcare's Shares Outstanding (Diluted Average) surged by 215.29% in 2024, and later surged by 975.83% in 2025.
  • Quarter analysis of 4 years shows Alignment Healthcare's Shares Outstanding (Diluted Average) stood at $181.2 million in 2022, then increased by 2.76% to $186.2 million in 2023, then rose by 2.46% to $190.8 million in 2024, then increased by 9.5% to $208.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $208.9 million in Q3 2025, compared to $209.5 million in Q2 2025 and $193.6 million in Q1 2025.